Antigenic properties of the merozoite surface protein 1 gene of Plasmodium vivax

被引:22
作者
de Oliveira, CI
Wunderlich, G
Levitus, G
Soares, IS
Rodrigues, MM
Tsuji, M
del Portillo, HA
机构
[1] Univ Sao Paulo, Inst Ciencias Biomed 2, Dept Parasitol, BR-05508900 Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil
[3] NYU, Med Ctr, Dept Med & Mol Pharmacol, New York, NY USA
基金
巴西圣保罗研究基金会;
关键词
Plasmodium vivax; merozoite surface protein 1; DNA vaccines;
D O I
10.1016/S0264-410X(99)00176-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plasmodium vivax is responsible for an approximate 35 million yearly human cases of malaria. Unfortunately, due to the low mortality rate associated with it and the difficulties of continuously in vitro culturing of this parasite, vaccine development against this human malaria has been largely neglected. In here, the antigenic properties of the merozoite surface protein 1 gene of P. vivax (PvMSP-1), were studied. Thus, seven recombinant bacterial plasmids coding different regions of the PvMSP-1 protein were constructed and used to immunize BALB/c mice, The results demonstrated that a plasmid encoding the entire N-terminus comprising 682 amino acids and a plasmid encoding the C-terminus including the two juxtaposed epidermal growth factor (EGF)-like domains fused to the Hepatitis B surface antigen, were antigenic. Moreover, the elicited immune responses were similar to those reported for these same PvMSP-1 regions in natural human infections. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2959 / 2968
页数:10
相关论文
共 43 条
[11]   DNA vaccines [J].
Donnelly, JJ ;
Ulmer, JB ;
Shiver, JW ;
Liu, MA .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :617-648
[12]   Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8(+) T cell-, interferon gamma-, and nitric oxide-dependent immunity [J].
Doolan, DL ;
Sedegah, M ;
Hedstrom, RC ;
Hobart, P ;
Charoenvit, Y ;
Hoffman, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1739-1746
[13]   Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: Evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds [J].
Egan, A ;
Waterfall, M ;
Pinder, M ;
Holder, A ;
Riley, E .
INFECTION AND IMMUNITY, 1997, 65 (08) :3024-3031
[14]   Plasmodium vivax: Merozoites, invasion of reticulocytes and considerations for malaria vaccine development [J].
Galinski, MR ;
Barnwell, JW .
PARASITOLOGY TODAY, 1996, 12 (01) :20-29
[15]   Pathways and strategies for developing a malaria blood-stage vaccine [J].
Good, MF ;
Kaslow, DC ;
Miller, LH .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :57-87
[16]  
Grifantini R, 1998, EUR J IMMUNOL, V28, P1225, DOI 10.1002/(SICI)1521-4141(199804)28:04<1225::AID-IMMU1225>3.0.CO
[17]  
2-6
[18]   MAJOR SURFACE-ANTIGEN GENE OF A HUMAN MALARIA PARASITE CLONED AND EXPRESSED IN BACTERIA [J].
HALL, R ;
HYDE, JE ;
GOMAN, M ;
SIMMONS, DL ;
HOPE, IA ;
MACKAY, M ;
SCAIFE, J ;
MERKLI, B ;
RICHLE, R ;
STOCKER, J .
NATURE, 1984, 311 (5984) :379-382
[19]  
Hirunpetcharat C, 1997, J IMMUNOL, V159, P3400
[20]  
HOLDER AA, 1988, PROG ALLERGY, V41, P72